155 related articles for article (PubMed ID: 20377821)
21. Impact of donepezil treatment for Alzheimer's disease on caregiver time.
Wimo A; Winblad B; Shah SN; Chin W; Zhang R; McRae T
Curr Med Res Opin; 2004 Aug; 20(8):1221-5. PubMed ID: 15324524
[TBL] [Abstract][Full Text] [Related]
22. Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease.
Paleacu D; Mazeh D; Mirecki I; Even M; Barak Y
Clin Neuropharmacol; 2002; 25(6):313-7. PubMed ID: 12469005
[TBL] [Abstract][Full Text] [Related]
23. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease.
Cummings JL; Donohue JA; Brooks RL
Am J Geriatr Psychiatry; 2000; 8(2):134-40. PubMed ID: 10804074
[TBL] [Abstract][Full Text] [Related]
24. Impact of donepezil on caregiving burden for patients with Alzheimer's disease.
Fillit HM; Gutterman EM; Brooks RL
Int Psychogeriatr; 2000 Sep; 12(3):389-401. PubMed ID: 11081959
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.
Gauthier S; Feldman H; Hecker J; Vellas B; Ames D; Subbiah P; Whalen E; Emir B;
Int Psychogeriatr; 2002 Dec; 14(4):389-404. PubMed ID: 12670060
[TBL] [Abstract][Full Text] [Related]
26. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Feldman H; Gauthier S; Hecker J; Vellas B; Hux M; Xu Y; Schwam EM; Shah S; Mastey V;
Neurology; 2004 Aug; 63(4):644-50. PubMed ID: 15326236
[TBL] [Abstract][Full Text] [Related]
27. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.
O'Brien BJ; Goeree R; Hux M; Iskedjian M; Blackhouse G; Gagnon M; Gauthier S
J Am Geriatr Soc; 1999 May; 47(5):570-8. PubMed ID: 10323651
[TBL] [Abstract][Full Text] [Related]
29. Effects of cholinergic drugs and cognitive training on dementia.
Requena C; López Ibor MI; Maestú F; Campo P; López Ibor JJ; Ortiz T
Dement Geriatr Cogn Disord; 2004; 18(1):50-4. PubMed ID: 15084794
[TBL] [Abstract][Full Text] [Related]
30. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study.
Samuel W; Caligiuri M; Galasko D; Lacro J; Marini M; McClure FS; Warren K; Jeste DV
Int J Geriatr Psychiatry; 2000 Sep; 15(9):794-802. PubMed ID: 10984725
[TBL] [Abstract][Full Text] [Related]
31. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.
Weiner MF; Martin-Cook K; Foster BM; Saine K; Fontaine CS; Svetlik DA
J Clin Psychiatry; 2000 Jul; 61(7):487-92. PubMed ID: 10937606
[TBL] [Abstract][Full Text] [Related]
32. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
Thomas DA; Libon DJ; Ledakis GE
Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
[TBL] [Abstract][Full Text] [Related]
33. An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer's disease.
Hager K; Calabrese P; Frölich L; Göbel C; Berger FM
Dement Geriatr Cogn Disord; 2003; 15(4):189-98. PubMed ID: 12626851
[TBL] [Abstract][Full Text] [Related]
34. Urinary incontinence: an unrecognised adverse effect with donepezil.
Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.
Holmes C; Wilkinson D; Dean C; Vethanayagam S; Olivieri S; Langley A; Pandita-Gunawardena ND; Hogg F; Clare C; Damms J
Neurology; 2004 Jul; 63(2):214-9. PubMed ID: 15277611
[TBL] [Abstract][Full Text] [Related]
36. Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease.
Frölich L; Klinger T; Berger FM
J Neurol Sci; 2002 Nov; 203-204():137-9. PubMed ID: 12417372
[TBL] [Abstract][Full Text] [Related]
37. First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary.
Whitehouse PJ; Winblad B; Shostak D; Bhattacharjya A; Brod M; Brodaty H; Dor A; Feldman H; Forette F; Gauthier S; Hay J; Henke C; Hill S; Mastey V; Neumann P; O'Brien B; Pugner K; Sano M; Sawada T; Stone R; Wimo A
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):266-80. PubMed ID: 9876955
[TBL] [Abstract][Full Text] [Related]
38. Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type.
Bergman J; Brettholz I; Shneidman M; Lerner V
Clin Neuropharmacol; 2003; 26(2):88-92. PubMed ID: 12671528
[TBL] [Abstract][Full Text] [Related]
39. Sustained cognitive improvement following treatment of Alzheimer's disease with donepezil.
Evans M; Ellis A; Watson D; Chowdhury T
Int J Geriatr Psychiatry; 2000 Jan; 15(1):50-3. PubMed ID: 10637404
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of donepezil in treating Alzheimer's disease.
Garcia A
Can Fam Physician; 1999 Aug; 45():1858-9. PubMed ID: 10463081
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
